Significance of laboratory findings for the diagnosis of neurosyphilis

Citation
Af. Luger et al., Significance of laboratory findings for the diagnosis of neurosyphilis, INT J STD A, 11(4), 2000, pp. 224-234
Citations number
47
Categorie Soggetti
Clinical Immunolgy & Infectious Disease
Journal title
INTERNATIONAL JOURNAL OF STD & AIDS
ISSN journal
09564624 → ACNP
Volume
11
Issue
4
Year of publication
2000
Pages
224 - 234
Database
ISI
SICI code
0956-4624(200004)11:4<224:SOLFFT>2.0.ZU;2-I
Abstract
Our objective is to assess the specificity and sensitivity, and thus elabor ate the relevance, of different laboratory findings for the diagnosis of ne urosyphilis. One hundred and fourteen HIV-negative pairs of serum and cerebrospinal flui d (CSF) samples were examined by the Venereal Disease Research Laboratory ( VDRL) test, a fluorescent treponemal antibody-absorption (FTA-ABS) test, mi crohaemagglutination assay with Treponema pallidum antigen (MHA-TP) test (s erum) and Treponema pallidum haemagglutination assay (TPHA) test (CSF); fur ther, albumin, total protein, and total IgG were determined and, in the CSF , cell count was performed. The donors were 60 patients with active neurosy philis and 54 healthy persons with a former history of syphilis and with pe rsisting positive results in the T. pallidum haemagglutination tests (serum : MHA-TP, CSF: TPHA), who supplied specimens for control. Albumin quotient, IgG index, TPHA index, modified TPHA index, Intrathecally produced T. pall idum Antigen (ITpA) index, its 2 modifications and, in 12 samples, the aden ovirus group antibody (AVGA)/TPHA index were ascertained. The specificity and sensitivity of the TPHA index were 100% and 98.3%, of t he modified TPHA index 50.0% and 96.7%, of the ITpA index 42.6% and 90.0%, of the modified ITpA indices 51.8% and 68.3% (first modification) and 53.7% and 63.3% (second modification). The AVGA/TPHA index yielded a specificity of 91.7% (11/12). The CSF VDRL test was positive in 55/60 (91.7%) of sampl es from patients with neurosyphilis and in none of the controls (0/54). A C SF-TPHA titre greater than 1:320 was observed in 59/60 (98.3%) of the neuro syphilis specimens and in none of the controls (0/54). A TPHA index above an outcome of 70, a positive CSF-TPHA test at a titre gr eater than 1:320 and, with lower sensitivity, the criteria of the Centers f or Disease Control (CDC) guidelines yield the most reliable results for lab oratory support to a diagnosis of neurosyphilis. The modified TPHA index, t he ITpA index, and its 2 modifications produce results of minor sensitivity and poor specificity. Observations on the AVGA/THPA index are too limited yet for judgement. The diagnostic significance of a CSF-TPHA titre above 32 0 needs further confirmation on a greater number of observations made by di fferent laboratories.